Oric Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Welcome, everybody, to the 40th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analyst here at JPMorgan. I'm joined by [Malcolm Kuno], Priyanka Grover and Caleb Smith from the team. Our next presenting company is ORIC, and presenting on behalf of the company, we have CEO, Jacob Chacko. (Operator Instructions) With that, Jacob, take it away.
Thanks, Anupam. Thanks for having us. It's our pleasure to talk to you today about ORIC Pharmaceuticals. We've only got, I think, about 20 minutes to go through quite a bit of information in the slide, so I'm going to go at a decent clip and then, Anupam, make sure to save enough time for Q&A at the end.
So Slide 2, just walk through some of the standard forward-looking statements, but let's jump right into the presentation on Slide 3. And this in one slide I think encapsulates why we were so excited about what we're
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |